Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Lichtenegger FS"'
Autor:
Hänel G; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Angerer C; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Petry K; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Lichtenegger FS; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.; Roche Innovation Center Munich, Penzberg, Germany., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. marion.subklewe@med.uni-muenchen.de.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany. marion.subklewe@med.uni-muenchen.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. marion.subklewe@med.uni-muenchen.de.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Jul; Vol. 71 (7), pp. 1705-1718. Date of Electronic Publication: 2021 Nov 25.
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody.
Autor:
Augsberger C; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Hänel G; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Xu W; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Pulko V; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Hanisch LJ; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Augustin A; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Challier J; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Hunt K; Research Unit Apoptosis in Hematopoietic Stem Cells (AHS), Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany., Vick B; Research Unit Apoptosis in Hematopoietic Stem Cells (AHS), Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany., Rovatti PE; Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Krupka C; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Rothe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Schönle A; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Sam J; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Lezan E; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Ducret A; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Ortiz-Franyuti D; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Walz AC; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Benz J; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Bujotzek A; Roche Pharma Research & Early Development, Roche Innovation Center Munich, Penzberg, Germany., Lichtenegger FS; Roche Pharma Research & Early Development, Roche Innovation Center Munich, Penzberg, Germany., Gassner C; Roche Pharma Research & Early Development, Roche Innovation Center Munich, Penzberg, Germany., Carpy A; Roche Pharma Research & Early Development, Roche Innovation Center Munich, Penzberg, Germany., Lyamichev V; Nimble Therapeutics, Madison, WI., Patel J; Nimble Therapeutics, Madison, WI., Konstandin N; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Tunger A; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases, Partner Site Dresden, Dresden, Germany., Schmitz M; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases, Partner Site Dresden, Dresden, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., von Bergwelt-Baildon M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Spiekermann K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Vago L; Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Jeremias I; Research Unit Apoptosis in Hematopoietic Stem Cells (AHS), Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany; and.; Department of Pediatrics, Dr von Hauner Children's Hospital, Ludwig Maximilian University (LMU), Munich, Germany., Marrer-Berger E; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Umaña P; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Klein C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Blood [Blood] 2021 Dec 23; Vol. 138 (25), pp. 2655-2669.
Autor:
Schwaab J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Naumann N; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Luebke J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Jawhar M; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Somervaille TCP; Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.; Cancer Research UK Manchester Institute, Manchester, UK., Williams MS; Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.; Cancer Research UK Manchester Institute, Manchester, UK., Frewin R; Department of Pathology, Gloucester Royal Hospital, Gloucester, UK., Jost PJ; III. Medical Department, Hematology and Oncology, Klinikum rechts der Isar, Technical University Munich, Munchen, Bayern, Germany., Lichtenegger FS; Department of Medicine III, University Hospital LMU Munich, Munich, Germany., La Rosée P; Klinik für Innere Medizin II, Schwarzwald-Baar-Klinikum, Villingen-Schwenningen, Germany., Storch N; Department of Hematology and Oncology, St. Vincenz Medical Centre, Limburg, Germany., Haferlach T; Munich Leukemia Laboratory, Munich, Germany., Horny HP; Department of Pathology, University of Munich, Munich, Germany., Fabarius A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Haferlach C; Munich Leukemia Laboratory, Munich, Germany., Burchert A; Department of Hematology, Oncology and Immunology, Philipps University Marburg, and University Medical Center Giessen and Marburg, Marburg, Germany., Hofmann WK; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Cross NCP; Faculty of Medicine, University of Southampton, Southampton, UK.; Wessex Regional Genetics Laboratory, Salisbury, UK., Hochhaus A; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Reiter A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Metzgeroth G; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Publikováno v:
American journal of hematology [Am J Hematol] 2020 Jul; Vol. 95 (7), pp. 824-833. Date of Electronic Publication: 2020 Apr 28.
Autor:
Ruzicka M; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany., Koenig LM; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Formisano S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany., Boehmer DFR; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany., Vick B; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Heuer EM; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany., Meinl H; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany., Kocheise L; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany., Zeitlhöfler M; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany., Ahlfeld J; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Kobold S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany., Endres S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany., Duewell P; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany., Schnurr M; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany., Jeremias I; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany., Lichtenegger FS; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Rothenfusser S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany. simon.rothenfusser@med.uni-muenchen.de.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany. simon.rothenfusser@med.uni-muenchen.de.
Publikováno v:
Leukemia [Leukemia] 2020 Apr; Vol. 34 (4), pp. 1017-1026. Date of Electronic Publication: 2019 Nov 18.
Autor:
Lichtenegger FS; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; Present address: Roche Innovation Center Munich Penzberg Germany., Schnorfeil FM; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany.; Present address: Medigene AG Planegg Germany., Rothe M; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Deiser K; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Altmann T; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Bücklein VL; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Köhnke T; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Augsberger C; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Konstandin NP; Department of Medicine III University Hospital, LMU Munich Munich Germany., Spiekermann K; Department of Medicine III University Hospital, LMU Munich Munich Germany., Moosmann A; DZIF Research Group 'Host Control of Viral Latency and Reactivation' (HOCOVLAR) Helmholtz Zentrum München Munich Germany., Boehm S; Max von Pettenkofer Institute LMU Munich Munich Germany., Boxberg M; Institute of Pathology Technical University of Munich Munich Germany., Heemskerk MH; Department of Hematology Leiden University Medical Center Leiden The Netherlands., Goerlich D; Institute of Biostatistics and Clinical Research University of Muenster Muenster Germany., Wittmann G; Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology University Hospital LMU Munich Munich Germany., Wagner B; Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology University Hospital LMU Munich Munich Germany., Hiddemann W; Department of Medicine III University Hospital, LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany., Schendel DJ; Medigene AG Planegg Germany., Kvalheim G; Department of Cellular Therapy The Norwegian Radium Hospital Oslo University Hospital Oslo Norway., Bigalke I; Department of Cellular Therapy The Norwegian Radium Hospital Oslo University Hospital Oslo Norway.; Present address: BioNTech IMFS Idar-Oberstein Germany., Subklewe M; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany.
Publikováno v:
Clinical & translational immunology [Clin Transl Immunology] 2020 Mar 03; Vol. 9 (3), pp. e1117. Date of Electronic Publication: 2020 Mar 03 (Print Publication: 2020).
Autor:
Van Acker HH; Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, 2610 Wilrijk, Antwerp, Belgium. heleen.vanacker@uantwerpen.be., Versteven M; Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, 2610 Wilrijk, Antwerp, Belgium. maarten.versteven@uantwerpen.be., Lichtenegger FS; Department of Medicine III, LMU Munich, University Hospital, 80799 Munich, Germany. F.Lichtenegger@gmx.de., Roex G; Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, 2610 Wilrijk, Antwerp, Belgium. gils.roex@uantwerpen.be., Campillo-Davo D; Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, 2610 Wilrijk, Antwerp, Belgium. Diana.CampilloDavo@uantwerpen.be., Lion E; Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, 2610 Wilrijk, Antwerp, Belgium. eva.lion@uza.be., Subklewe M; Department of Medicine III, LMU Munich, University Hospital, 80799 Munich, Germany. Marion.Subklewe@med.uni-muenchen.de., Van Tendeloo VF; Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, 2610 Wilrijk, Antwerp, Belgium. vigske@gmail.com., Berneman ZN; Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, 2610 Wilrijk, Antwerp, Belgium. zwi.berneman@uza.be.; Division of Hematology and Center for Cell Therapy & Regenerative Medicine, Antwerp University Hospital, 2650 Edegem, Antwerp, Belgium. zwi.berneman@uza.be., Anguille S; Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, Faculty of Medicine & Health Sciences, University of Antwerp, 2610 Wilrijk, Antwerp, Belgium. sebastien.anguille@uza.be.; Division of Hematology and Center for Cell Therapy & Regenerative Medicine, Antwerp University Hospital, 2650 Edegem, Antwerp, Belgium. sebastien.anguille@uza.be.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2019 Apr 27; Vol. 8 (5). Date of Electronic Publication: 2019 Apr 27.
Autor:
Haubner S; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.; Center for Cell Engineering and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Perna F; Center for Cell Engineering and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Köhnke T; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Schmidt C; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Berman S; Center for Cell Engineering and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Augsberger C; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Schnorfeil FM; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Krupka C; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Lichtenegger FS; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Liu X; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Kerbs P; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Schneider S; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Metzeler KH; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Spiekermann K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Hiddemann W; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Greif PA; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Herold T; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Sadelain M; Center for Cell Engineering and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. marion.subklewe@med.uni-muenchen.de.; Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany. marion.subklewe@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. marion.subklewe@med.uni-muenchen.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. marion.subklewe@med.uni-muenchen.de.
Publikováno v:
Leukemia [Leukemia] 2019 Jan; Vol. 33 (1), pp. 64-74. Date of Electronic Publication: 2018 Jun 26.
Autor:
Lichtenegger FS; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Rothe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Schnorfeil FM; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Deiser K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Krupka C; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Augsberger C; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Schlüter M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Neitz J; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2018 Feb 27; Vol. 9, pp. 385. Date of Electronic Publication: 2018 Feb 27 (Print Publication: 2018).
Autor:
Lichtenegger FS; Department of Medicine III, University Hospital, LMU Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center, Munich, Germany., Krupka C; Department of Medicine III, University Hospital, LMU Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center, Munich, Germany., Haubner S; Department of Medicine III, University Hospital, LMU Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center, Munich, Germany., Köhnke T; Department of Medicine III, University Hospital, LMU Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center, Munich, Germany., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Germany. Marion.Subklewe@med.uni-muenchen.de.; Laboratory of Translational Cancer Immunology, Gene Center, Munich, Germany. Marion.Subklewe@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site, Munich, Germany. Marion.Subklewe@med.uni-muenchen.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. Marion.Subklewe@med.uni-muenchen.de.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2017 Jul 25; Vol. 10 (1), pp. 142. Date of Electronic Publication: 2017 Jul 25.
Autor:
Krupka C; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany., Lichtenegger FS; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany., Köhnke T; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany., Bögeholz J; Department of Hematology, University Hospital Zurich, Zurich, Switzerland., Bücklein V; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany., Roiss M; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany., Altmann T; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany., Do TU; Independent consultant Oxford BioTherapeutics Ltd, Abingdon, United Kingdom and San Jose, CA, USA., Dusek R; Independent consultant Oxford BioTherapeutics Ltd, Abingdon, United Kingdom and San Jose, CA, USA., Wilson K; Independent consultant Oxford BioTherapeutics Ltd, Abingdon, United Kingdom and San Jose, CA, USA., Bisht A; Independent consultant Oxford BioTherapeutics Ltd, Abingdon, United Kingdom and San Jose, CA, USA., Terrett J; CRISPR Therapeutics, Cambridge, MA, USA., Aud D; CRISPR Therapeutics, Cambridge, MA, USA., Pombo-Villar E; Independent consultant Oxford BioTherapeutics Ltd, Abingdon, United Kingdom and San Jose, CA, USA., Rohlff C; Independent consultant Oxford BioTherapeutics Ltd, Abingdon, United Kingdom and San Jose, CA, USA., Hiddemann W; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany., Subklewe M; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany.
Publikováno v:
Oncotarget [Oncotarget] 2017 May 30; Vol. 8 (22), pp. 35707-35717.